Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03665415 · ClinicalTrials.gov registry record · NA
Expanded Game Squad for Neurodiverse Youth
A NA study, sponsored by Merrimack College.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03665415: Completed NA study, sponsored by Merrimack College.
NCT03665415 is a NA study that has completed, run by Merrimack College. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03665415, a NA study, has completed, sponsored by Merrimack College.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The proposed study will pilot the use of an adapted Game Squad intervention aimed at improving physical activity and other important health behaviors (nutrition, sleep hygiene, screen time habits) for children and adolescents receiving special education supports for behavioral health challenges, or who are served by the Boston Medical Center Developmental and Behavioral Pediatrics (BMC-DBP) clinic.
Primary Outcome
Change in moderate to vigorous physical activity measured via hip-worn Actigraph accelerometer
Interventions
- BEHAVIORAL NDGameSquad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03665415 record still lists
NCT03665415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which NDGameSquad is the first listed.
NCT03665415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03665415 about?
NCT03665415 is a clinical study titled "Expanded Game Squad for Neurodiverse Youth". The proposed study will pilot the use of an adapted Game Squad intervention aimed at improving physical activity and other important health behaviors (nutrition, sleep hygiene, screen time habits) for children and adolescents receiving special education supports for behavioral health challenges, or ...
What is the current status of trial NCT03665415?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2018-11-06. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03665415?
The interventions under investigation include: NDGameSquad (BEHAVIORAL).
Who is sponsoring clinical trial NCT03665415?
This trial is sponsored by Merrimack College, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03665415's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI